Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00335764
Status:
COMPLETED
Last Update Posted:
2018-07-02
First Post:
2006-06-08
Brief Title:
Sorafenib Combined With Erlotinib Tipifarnib or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Sponsor:
Organization:
National Cancer Institute NCI